What is the difference between pulmonary arteries and bronchial arteries, and can Computed Tomography Pulmonary Angiography (CTPA) help identify bronchial arteries in a patient with hemoptysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2025 • View editorial policy

From the Guidelines

CTPA can be beneficial in detecting bronchial and nonbronchial arteries in patients with hemoptysis, with studies showing a high concordance rate between CTA and conventional arteriography 1. Pulmonary arteries and bronchial arteries differ significantly in their origin, function, and the type of blood they carry. Pulmonary arteries originate from the right ventricle and are responsible for carrying deoxygenated blood to the lungs for oxygenation, forming the pulmonary circulation. In contrast, bronchial arteries arise from the thoracic aorta or its branches, supplying oxygenated blood to the bronchi, bronchioles, and the supporting structures of the lungs as part of the systemic circulation.

Key Differences and Diagnostic Approaches

  • Origin and Function: The primary distinction lies in their origin and the role they play in the circulatory system.
  • Blood Type: Pulmonary arteries carry deoxygenated blood, while bronchial arteries carry oxygenated blood.
  • Diagnostic Tools: For diagnosing issues related to these arteries, especially in cases of hemoptysis, CTPA (CT Pulmonary Angiography) and CTA (CT Angiography) are valuable tools.

Role of CTPA in Hemoptysis

CTPA is primarily used to evaluate pulmonary arteries, especially for detecting pulmonary embolism. However, it can also be useful in identifying bronchial arteries, particularly when they are enlarged or abnormal, as is often the case in patients with hemoptysis. Studies have shown that CTA can guide embolization therapy and has a high concordance rate with conventional arteriography in identifying the source of bleeding in hemoptysis patients 1.

Limitations and Alternatives

While CTPA can be beneficial, its ability to visualize bronchial arteries might be limited compared to dedicated CT Bronchial Angiography protocols or conventional catheter angiography. For severe or recurrent hemoptysis, conventional catheter angiography remains the gold standard for detailed evaluation of bronchial arteries and offers the potential for therapeutic embolization during the procedure.

Clinical Application

In clinical practice, the choice between CTPA and other diagnostic tools depends on the severity of hemoptysis, the availability of resources, and the clinical suspicion of the underlying cause. Given the high concordance rate between CTA and conventional arteriography, as documented by Remy-Jardin et al and others 1, CTPA can be a valuable initial step in the diagnostic workup for patients with hemoptysis, especially when there is a suspicion of bronchial artery involvement. However, the decision to proceed with CTPA should be made considering the individual patient's presentation and the potential need for subsequent conventional angiography for both diagnostic and therapeutic purposes.

From the Research

Difference between Pulmonary Arteries and Bronchial Arteries

  • Pulmonary arteries carry deoxygenated blood from the heart to the lungs, while bronchial arteries supply oxygenated blood to the lungs and airways 2, 3.
  • The bronchial arteries are responsible for supplying blood to the bronchi, bronchioles, and lung parenchyma, and are often involved in cases of hemoptysis 4, 5.

Role of CTPA in Evaluating Bronchial Arteries

  • Computed Tomography Pulmonary Angiography (CTPA) can be used to evaluate both pulmonary and bronchial arteries, and can help identify the source of bleeding in cases of hemoptysis 2, 4.
  • CTPA can be combined with bronchial angiography (CTBA) to provide a more comprehensive evaluation of the bronchial arteries and identify abnormal vessels 4.
  • The use of CTPA and CTBA can help guide therapeutic arterial embolization procedures, such as bronchial artery embolization (BAE), which is a effective treatment for massive and recurrent hemoptysis 2, 3, 5, 6.

Evaluation and Management of Hemoptysis

  • Hemoptysis is a potentially life-threatening condition that requires prompt evaluation and treatment 2, 3, 5, 6.
  • The initial evaluation of hemoptysis should include a thorough history and physical examination, chest radiography, and computed tomography (CT) of the chest 3, 5, 6.
  • Bronchoscopy may also be necessary to identify the source of bleeding and to guide treatment 2, 3, 5, 6.
  • Treatment of hemoptysis depends on the underlying cause and severity of bleeding, and may include supportive medical treatment, bronchial artery embolization, and surgery 2, 3, 5, 6.

References

Guideline

acr appropriateness criteria® hemoptysis.

Journal of the American College of Radiology, 2020

Research

Imaging and interventional radiological treatment of hemoptysis.

Acta radiologica (Stockholm, Sweden : 1987), 2006

Research

[The evaluation of combined CT pulmonary and bronchial arteriography for the diagnosis of hemoptysis].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2012

Research

Hemoptysis: Evaluation and Management.

American family physician, 2022

Research

The Diagnosis and Treatment of Hemoptysis.

Deutsches Arzteblatt international, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.